Crossmark

Comparative efficacy and safety of IL-17 and IL-23 inhibitors for moderate-to-severe psoriasis in Asian populations: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12865-025-00789-2

Published Online: 2026-02-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alzghool, Mohammad https://orcid.org/0009-0007-7719-1545
Jiquan, Song

Bashir, Musa Bin https://orcid.org/0000-0001-9678-0512
License Information

Text and Data Mining valid from 2026-02-03

Version of Record valid from 2026-03-03
More Information

Article History

Received: 20 June 2025

Accepted: 3 December 2025

First Online: 3 February 2026

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below